Abstract
Penicillamine therapy was associated with the development of thrombohemolytic thrombocytopenic purpura (TTP) in a 23-yr-old woman. The immunological and hematological toxicity of penicillamine and the occurrence of TTP with parent penicillin compounds indicates a probable etiological role of this drug.

This publication has 2 references indexed in Scilit: